Genzyme Molecular Oncology of Framingham, Mass., has exclusively licensed certain high density DNA array diagnostic and research rights related to the p53 gene to Affymetrix for use on its GeneChip arrays.
Affymetrix currently sells p53 arrays that analyze the coding region of the p53 tumor suppressor gene.
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
You may already have institutional access!
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
